Supplementary Figure S1 from S49076 Is a Novel Kinase Inhibitor of MET, AXL, and FGFR with Strong Preclinical Activity Alone and in Association with Bevacizumab Article Swipe

View

Mike F. Burbridge , Céline Bossard , Carine Saunier , Imre Fejes , Alain Bruno , Stéphane Léonce , Gilles Ferry , Georges Da Violante , François Bouzom , Valérie Cattan , Anne Jacquet-Bescond , Paolo M. Comoglio , Brian Lockhart , Jean A. Boutin , Alex Cordi , Jean‐Claude Ortuno , Alain St. Pierre , John A. Hickman , Francisco Cruzalegui , Stéphane Depil ·

YOU? · · 2023 · Open Access · · DOI: https://doi.org/10.1158/1535-7163.22500589.v1

Western blot detection of total and phosphorylated MET, AXL, FGFR1/2/3 and phosphorylated FRS2 in cell lines and tumor xenografts used in the study

Related Topics

Concepts

Bevacizumab Kinase Cancer research Pharmacology Medicine Internal medicine Chemistry Biochemistry Chemotherapy

Metadata

Type: preprint
Language: en
Landing Page: https://doi.org/10.1158/1535-7163.22500589.v1
OA Status: gold
Related Works: 10
OpenAlex ID: https://openalex.org/W4362621448

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4362621448

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1158/1535-7163.22500589.v1

Digital Object Identifier
Title: Supplementary Figure S1 from S49076 Is a Novel Kinase Inhibitor of MET, AXL, and FGFR with Strong Preclinical Activity Alone and in Association with Bevacizumab

Work title
Type: preprint

OpenAlex work type
Language: en

Primary language
Publication year: 2023

Year of publication
Publication date: 2023-04-03

Full publication date if available
Authors: Mike F. Burbridge, Céline Bossard, Carine Saunier, Imre Fejes, Alain Bruno, Stéphane Léonce, Gilles Ferry, Georges Da Violante, François Bouzom, Valérie Cattan, Anne Jacquet-Bescond, Paolo M. Comoglio, Brian Lockhart, Jean A. Boutin, Alex Cordi, Jean‐Claude Ortuno, Alain St. Pierre, John A. Hickman, Francisco Cruzalegui, Stéphane Depil

List of authors in order
Landing page: https://doi.org/10.1158/1535-7163.22500589.v1

Publisher landing page
Open access: Yes

Whether a free full text is available
OA status: gold

Open access status per OpenAlex
OA URL: https://doi.org/10.1158/1535-7163.22500589.v1

Direct OA link when available
Concepts: Bevacizumab, Kinase, Cancer research, Pharmacology, Medicine, Internal medicine, Chemistry, Biochemistry, Chemotherapy

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4362621448
doi	https://doi.org/10.1158/1535-7163.22500589.v1
ids.doi	https://doi.org/10.1158/1535-7163.22500589.v1
ids.openalex	https://openalex.org/W4362621448
fwci
type	preprint
title	Supplementary Figure S1 from S49076 Is a Novel Kinase Inhibitor of MET, AXL, and FGFR with Strong Preclinical Activity Alone and in Association with Bevacizumab
biblio.issue
biblio.volume
biblio.last_page
biblio.first_page
topics[0].id	https://openalex.org/T12287
topics[0].field.id	https://openalex.org/fields/13
topics[0].field.display_name	Biochemistry, Genetics and Molecular Biology
topics[0].score	0.9944000244140625
topics[0].domain.id	https://openalex.org/domains/1
topics[0].domain.display_name	Life Sciences
topics[0].subfield.id	https://openalex.org/subfields/1312
topics[0].subfield.display_name	Molecular Biology
topics[0].display_name	Fibroblast Growth Factor Research
topics[1].id	https://openalex.org/T10631
topics[1].field.id	https://openalex.org/fields/13
topics[1].field.display_name	Biochemistry, Genetics and Molecular Biology
topics[1].score	0.963100016117096
topics[1].domain.id	https://openalex.org/domains/1
topics[1].domain.display_name	Life Sciences
topics[1].subfield.id	https://openalex.org/subfields/1306
topics[1].subfield.display_name	Cancer Research
topics[1].display_name	Cancer, Hypoxia, and Metabolism
topics[2].id	https://openalex.org/T12104
topics[2].field.id	https://openalex.org/fields/13
topics[2].field.display_name	Biochemistry, Genetics and Molecular Biology
topics[2].score	0.958299994468689
topics[2].domain.id	https://openalex.org/domains/1
topics[2].domain.display_name	Life Sciences
topics[2].subfield.id	https://openalex.org/subfields/1312
topics[2].subfield.display_name	Molecular Biology
topics[2].display_name	Protein Tyrosine Phosphatases
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C2777802072
concepts[0].level	3
concepts[0].score	0.7139768600463867
concepts[0].wikidata	https://www.wikidata.org/wiki/Q413299
concepts[0].display_name	Bevacizumab
concepts[1].id	https://openalex.org/C184235292
concepts[1].level	2
concepts[1].score	0.5084820985794067
concepts[1].wikidata	https://www.wikidata.org/wiki/Q421851
concepts[1].display_name	Kinase
concepts[2].id	https://openalex.org/C502942594
concepts[2].level	1
concepts[2].score	0.4919867217540741
concepts[2].wikidata	https://www.wikidata.org/wiki/Q3421914
concepts[2].display_name	Cancer research
concepts[3].id	https://openalex.org/C98274493
concepts[3].level	1
concepts[3].score	0.37281981110572815
concepts[3].wikidata	https://www.wikidata.org/wiki/Q128406
concepts[3].display_name	Pharmacology
concepts[4].id	https://openalex.org/C71924100
concepts[4].level	0
concepts[4].score	0.3637779951095581
concepts[4].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[4].display_name	Medicine
concepts[5].id	https://openalex.org/C126322002
concepts[5].level	1
concepts[5].score	0.30019456148147583
concepts[5].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[5].display_name	Internal medicine
concepts[6].id	https://openalex.org/C185592680
concepts[6].level	0
concepts[6].score	0.2908942997455597
concepts[6].wikidata	https://www.wikidata.org/wiki/Q2329
concepts[6].display_name	Chemistry
concepts[7].id	https://openalex.org/C55493867
concepts[7].level	1
concepts[7].score	0.12154635787010193
concepts[7].wikidata	https://www.wikidata.org/wiki/Q7094
concepts[7].display_name	Biochemistry
concepts[8].id	https://openalex.org/C2776694085
concepts[8].level	2
concepts[8].score	0.08840769529342651
concepts[8].wikidata	https://www.wikidata.org/wiki/Q974135
concepts[8].display_name	Chemotherapy
keywords[0].id	https://openalex.org/keywords/bevacizumab
keywords[0].score	0.7139768600463867
keywords[0].display_name	Bevacizumab
keywords[1].id	https://openalex.org/keywords/kinase
keywords[1].score	0.5084820985794067
keywords[1].display_name	Kinase
keywords[2].id	https://openalex.org/keywords/cancer-research
keywords[2].score	0.4919867217540741
keywords[2].display_name	Cancer research
keywords[3].id	https://openalex.org/keywords/pharmacology
keywords[3].score	0.37281981110572815
keywords[3].display_name	Pharmacology
keywords[4].id	https://openalex.org/keywords/medicine
keywords[4].score	0.3637779951095581
keywords[4].display_name	Medicine
keywords[5].id	https://openalex.org/keywords/internal-medicine
keywords[5].score	0.30019456148147583
keywords[5].display_name	Internal medicine
keywords[6].id	https://openalex.org/keywords/chemistry
keywords[6].score	0.2908942997455597
keywords[6].display_name	Chemistry
keywords[7].id	https://openalex.org/keywords/biochemistry
keywords[7].score	0.12154635787010193
keywords[7].display_name	Biochemistry
keywords[8].id	https://openalex.org/keywords/chemotherapy
keywords[8].score	0.08840769529342651
keywords[8].display_name	Chemotherapy
language	en
locations[0].id	doi:10.1158/1535-7163.22500589.v1
locations[0].is_oa	True
locations[0].source
locations[0].license	cc-by
locations[0].pdf_url
locations[0].version	acceptedVersion
locations[0].raw_type	posted-content
locations[0].license_id	https://openalex.org/licenses/cc-by
locations[0].is_accepted	True
locations[0].is_published	False
locations[0].raw_source_name
locations[0].landing_page_url	https://doi.org/10.1158/1535-7163.22500589.v1
locations[1].id	pmh:oai:figshare.com:article/22500589
locations[1].is_oa	True
locations[1].source.id	https://openalex.org/S4306400572
locations[1].source.issn
locations[1].source.type	repository
locations[1].source.is_oa	False
locations[1].source.issn_l
locations[1].source.is_core	False
locations[1].source.is_in_doaj	False
locations[1].source.display_name	OPAL (Open@LaTrobe) (La Trobe University)
locations[1].source.host_organization	https://openalex.org/I196829312
locations[1].source.host_organization_name	La Trobe University
locations[1].source.host_organization_lineage	https://openalex.org/I196829312
locations[1].license	cc-by
locations[1].pdf_url
locations[1].version	submittedVersion
locations[1].raw_type	Image
locations[1].license_id	https://openalex.org/licenses/cc-by
locations[1].is_accepted	False
locations[1].is_published	False
locations[1].raw_source_name
locations[1].landing_page_url	https://figshare.com/articles/figure/Supplementary_Figure_S1_from_S49076_Is_a_Novel_Kinase_Inhibitor_of_MET_AXL_and_FGFR_with_Strong_Preclinical_Activity_Alone_and_in_Association_with_Bevacizumab/22500589
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5075016782
authorships[0].author.orcid
authorships[0].author.display_name	Mike F. Burbridge
authorships[0].author_position	first
authorships[0].raw_author_name	Mike F. Burbridge
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5064697535
authorships[1].author.orcid	https://orcid.org/0000-0002-4513-0007
authorships[1].author.display_name	Céline Bossard
authorships[1].author_position	middle
authorships[1].raw_author_name	Céline J. Bossard
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5078828743
authorships[2].author.orcid
authorships[2].author.display_name	Carine Saunier
authorships[2].author_position	middle
authorships[2].raw_author_name	Carine Saunier
authorships[2].is_corresponding	False
authorships[3].author.id	https://openalex.org/A5050336211
authorships[3].author.orcid	https://orcid.org/0000-0003-1337-0169
authorships[3].author.display_name	Imre Fejes
authorships[3].author_position	middle
authorships[3].raw_author_name	Imre Fejes
authorships[3].is_corresponding	False
authorships[4].author.id	https://openalex.org/A5104623404
authorships[4].author.orcid
authorships[4].author.display_name	Alain Bruno
authorships[4].author_position	middle
authorships[4].raw_author_name	Alain Bruno
authorships[4].is_corresponding	False
authorships[5].author.id	https://openalex.org/A5047398366
authorships[5].author.orcid
authorships[5].author.display_name	Stéphane Léonce
authorships[5].author_position	middle
authorships[5].raw_author_name	Stéphane Léonce
authorships[5].is_corresponding	False
authorships[6].author.id	https://openalex.org/A5004962594
authorships[6].author.orcid	https://orcid.org/0000-0003-0689-7923
authorships[6].author.display_name	Gilles Ferry
authorships[6].author_position	middle
authorships[6].raw_author_name	Gilles Ferry
authorships[6].is_corresponding	False
authorships[7].author.id	https://openalex.org/A5040843373
authorships[7].author.orcid
authorships[7].author.display_name	Georges Da Violante
authorships[7].author_position	middle
authorships[7].raw_author_name	Georges Da Violante
authorships[7].is_corresponding	False
authorships[8].author.id	https://openalex.org/A5063122652
authorships[8].author.orcid
authorships[8].author.display_name	François Bouzom
authorships[8].author_position	middle
authorships[8].raw_author_name	François Bouzom
authorships[8].is_corresponding	False
authorships[9].author.id	https://openalex.org/A5033349265
authorships[9].author.orcid
authorships[9].author.display_name	Valérie Cattan
authorships[9].author_position	middle
authorships[9].raw_author_name	Valérie Cattan
authorships[9].is_corresponding	False
authorships[10].author.id	https://openalex.org/A5005779956
authorships[10].author.orcid
authorships[10].author.display_name	Anne Jacquet-Bescond
authorships[10].author_position	middle
authorships[10].raw_author_name	Anne Jacquet-Bescond
authorships[10].is_corresponding	False
authorships[11].author.id	https://openalex.org/A5033662919
authorships[11].author.orcid	https://orcid.org/0000-0002-7056-5328
authorships[11].author.display_name	Paolo M. Comoglio
authorships[11].author_position	middle
authorships[11].raw_author_name	Paolo M. Comoglio
authorships[11].is_corresponding	False
authorships[12].author.id	https://openalex.org/A5008015346
authorships[12].author.orcid
authorships[12].author.display_name	Brian Lockhart
authorships[12].author_position	middle
authorships[12].raw_author_name	Brian P. Lockhart
authorships[12].is_corresponding	False
authorships[13].author.id	https://openalex.org/A5021383328
authorships[13].author.orcid	https://orcid.org/0000-0003-0068-7204
authorships[13].author.display_name	Jean A. Boutin
authorships[13].author_position	middle
authorships[13].raw_author_name	Jean A. Boutin
authorships[13].is_corresponding	False
authorships[14].author.id	https://openalex.org/A5110101726
authorships[14].author.orcid
authorships[14].author.display_name	Alex Cordi
authorships[14].author_position	middle
authorships[14].raw_author_name	Alex Cordi
authorships[14].is_corresponding	False
authorships[15].author.id	https://openalex.org/A5112902687
authorships[15].author.orcid
authorships[15].author.display_name	Jean‐Claude Ortuno
authorships[15].author_position	middle
authorships[15].raw_author_name	Jean-Claude Ortuno
authorships[15].is_corresponding	False
authorships[16].author.id	https://openalex.org/A5112028930
authorships[16].author.orcid
authorships[16].author.display_name	Alain St. Pierre
authorships[16].author_position	middle
authorships[16].raw_author_name	Alain Pierré
authorships[16].is_corresponding	False
authorships[17].author.id	https://openalex.org/A5013128561
authorships[17].author.orcid	https://orcid.org/0000-0002-6661-8175
authorships[17].author.display_name	John A. Hickman
authorships[17].author_position	middle
authorships[17].raw_author_name	John A. Hickman
authorships[17].is_corresponding	False
authorships[18].author.id	https://openalex.org/A5074833042
authorships[18].author.orcid
authorships[18].author.display_name	Francisco Cruzalegui
authorships[18].author_position	middle
authorships[18].raw_author_name	Francisco H. Cruzalegui
authorships[18].is_corresponding	False
authorships[19].author.id	https://openalex.org/A5062189345
authorships[19].author.orcid	https://orcid.org/0000-0001-6011-3945
authorships[19].author.display_name	Stéphane Depil
authorships[19].author_position	last
authorships[19].raw_author_name	Stéphane Depil
authorships[19].is_corresponding	False
has_content.pdf	False
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://doi.org/10.1158/1535-7163.22500589.v1
open_access.oa_status	gold
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Supplementary Figure S1 from S49076 Is a Novel Kinase Inhibitor of MET, AXL, and FGFR with Strong Preclinical Activity Alone and in Association with Bevacizumab
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T12287
primary_topic.field.id	https://openalex.org/fields/13
primary_topic.field.display_name	Biochemistry, Genetics and Molecular Biology
primary_topic.score	0.9944000244140625
primary_topic.domain.id	https://openalex.org/domains/1
primary_topic.domain.display_name	Life Sciences
primary_topic.subfield.id	https://openalex.org/subfields/1312
primary_topic.subfield.display_name	Molecular Biology
primary_topic.display_name	Fibroblast Growth Factor Research
related_works	https://openalex.org/W4380186280, https://openalex.org/W4238549103, https://openalex.org/W2020304503, https://openalex.org/W2398876361, https://openalex.org/W2589939875, https://openalex.org/W2192585329, https://openalex.org/W1976977209, https://openalex.org/W2339535453, https://openalex.org/W2265205727, https://openalex.org/W2014912105
cited_by_count	0
locations_count	2
best_oa_location.id	doi:10.1158/1535-7163.22500589.v1
best_oa_location.is_oa	True
best_oa_location.source
best_oa_location.license	cc-by
best_oa_location.pdf_url
best_oa_location.version	acceptedVersion
best_oa_location.raw_type	posted-content
best_oa_location.license_id	https://openalex.org/licenses/cc-by
best_oa_location.is_accepted	True
best_oa_location.is_published	False
best_oa_location.raw_source_name
best_oa_location.landing_page_url	https://doi.org/10.1158/1535-7163.22500589.v1
primary_location.id	doi:10.1158/1535-7163.22500589.v1
primary_location.is_oa	True
primary_location.source
primary_location.license	cc-by
primary_location.pdf_url
primary_location.version	acceptedVersion
primary_location.raw_type	posted-content
primary_location.license_id	https://openalex.org/licenses/cc-by
primary_location.is_accepted	True
primary_location.is_published	False
primary_location.raw_source_name
primary_location.landing_page_url	https://doi.org/10.1158/1535-7163.22500589.v1
publication_date	2023-04-03
publication_year	2023
referenced_works_count	0
abstract_inverted_index.in	13, 20
abstract_inverted_index.of	3
abstract_inverted_index.and	5, 10, 16
abstract_inverted_index.the	21
abstract_inverted_index.AXL,	8
abstract_inverted_index.FRS2	12
abstract_inverted_index.MET,	7
abstract_inverted_index.blot	1
abstract_inverted_index.cell	14
abstract_inverted_index.used	19
abstract_inverted_index.lines	15
abstract_inverted_index.total	4
abstract_inverted_index.tumor	17
abstract_inverted_index.FGFR1/2/3	9
abstract_inverted_index.detection	2
abstract_inverted_index.xenografts	18
abstract_inverted_index.phosphorylated	6, 11
abstract_inverted_index.study</p>	22
abstract_inverted_index.<p>Western	0
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	20
citation_normalized_percentile.value	0.21092732
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False